Literature DB >> 6760890

Nystatin-resistance of candida albicans isolates from two cases of oral candidiasis.

M V Martin, R C Dinsdale.   

Abstract

Two cases of oral candidiasis are described which failed to respond to nystatin therapy when used in combination with triamcinolone acetonide. The isolates of C. albicans obtained from the patients after treatment showed high in vitro resistance to nystatin when tested in combination with triamcinolone acetonide. Triamcinolone acetonide was detected in the saliva of both patients after treatment. Addition of this saliva to the isolates of C. albicans obtained after treatment was found to confer nystatin resistance. Both patients were treated with miconazole nitrate and a mycological and clinical cure was obtained in one of the cases.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6760890     DOI: 10.1016/s0007-117x(82)80026-7

Source DB:  PubMed          Journal:  Br J Oral Surg        ISSN: 0007-117X


  2 in total

1.  Antifungal application of nonantifungal drugs.

Authors:  Marios Stylianou; Evgeny Kulesskiy; José Pedro Lopes; Margareta Granlund; Krister Wennerberg; Constantin F Urban
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

2.  Nystatin-mediated bismuth oxide nano-drug synthesis using gamma rays for increasing the antimicrobial and antibiofilm activities against some pathogenic bacteria and Candida species.

Authors:  Ahmed I El-Batal; Hanady G Nada; Reham R El-Behery; Mohamed Gobara; Gharieb S El-Sayyad
Journal:  RSC Adv       Date:  2020-03-05       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.